KEP: Cancer Epidemiology Group

We aim to improve the understanding of determinants of risk and prognosis of cancer, with a special focus on malignant lymphomas and cancers arising after organ transplantation, as well as to characterize issues of cancer survivorship. The overall goal is to provide a better basis for primary prevention of cancer, prediction of risk and prognosis, and cancer rehabilitation.

Cancer epidemiology group

 

What we do

We aim to improve the understanding of cancer risk and survival, prognostic prediction and survivorship, with a focus on malignant lymphomas, prostate, breast and colorectal cancer and malignant melanomas. Our research is based on linkages of population-based health register data, often enriched with clinical data from national cancer quality registers and medical records, and we strive to address research questions of high clinical relevance. Examples of areas of specific interest are survival and relapse risk in Hodgkin lymphoma, diffuse large B-cell and follicular lymphoma, late adverse effects from cancer treatments such as risk of second malignancies or heart disease, and child birth potential among cancer survivors.

We collaborate closely with other research groups at KEP, other units at the Karolinska Institutet (MMK, CCK, MEB, IMM), researchers at other Swedish universities (Uppsala, Lund) and the Swedish Lymphoma group as well as internationally within the Nordic Lymphoma group and within the InterLymph consortium. In the ongoing clinical prospective Biolymph study, we work closely with the medical units of Hematology, Genetics and Pathology at the Karolinska hospital to improve diagnostics, prognostics and follow-up of patients with newly diagnosed lymphoma. This work also forms part of a pilot study within the Genomic Medicine Sweden.

Research funding

Our research is conducted thanks to financial support from the following funding bodies: Swedish Cancer Society, Nordic Cancer Union, Cancerföreningen and Stockholm County Council.

Social Media

Updates from our group are also available via our twitter account @CancerepiK.

Recent Publications

Lymphoma and myeloma

Other

Research Group Members